Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
SLNO
#1669
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+5.51%
Variazione Mensile
-9.20%
Variazione di 6 mesi
-42.34%
Variazione Annuale
-13.27%
Chiusura Precedente
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
Volume
143
Mercati
Mercato Azionario Statunitense
Salute
SLNO
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
43.12 M
45.86 M
50.39 M
53.15 M
53.71 M
51.62 M
—
Valuation ratios
Enterprise value
2.13 B
1.97 B
3.52 B
4.38 B
3.38 B
2.32 B
13.6 B
Price to earnings ratio
-18.63
-10.26
-15.07
-19.67
-34.49
118.72
49.49
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
-31.87
-26.14
-33.05
-42.95
-96.78
51.83
-120.95
Price to book ratio
1.82
7.37
2.81
3.66
2.6
5.39
14.46
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.17
0.14
0.01
0.04
-0.1
0.1
Return on equity %
0.29
0.23
0.19
0.02
0.05
-0.12
0.14
Return on invested capital %
—
116.71
—
—
—
-32.78
—
Gross margin %
—
—
—
97.87
98.27
—
—
Operating margin %
—
—
—
19.98
33.48
—
—
EBITDA margin %
—
—
—
-25.07
31.21
—
—
Net margin %
—
—
—
14.42
39.4
—
—
Liquidity ratios
Quick ratio
—
—
—
15.01
15.88
5.55
—
Current ratio
17.26
15.68
19.64
15.13
16.08
5.8
56.65
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
0.1
0.14
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.15
0.16
0.15
0.08
0.09
—
Long term debt to total equity ratio
—
0.2
0.21
0.21
0.1
0.11
—
Per share metrics
Operating cash flow per share
0.36
0.6
0.71
0.25
-0.79
0.86
1.02
EBIT per share
—
—
—
-0.14
0.38
—
—
EBITDA per share
—
—
—
-0.16
0.38
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
6.13
2.19
6.28
5.68
9.09
5.83
26.88
Net current asset value per share
6.17
7.32
6.69
6.28
9.74
6.79
29.5
Tangible book value per share
6.15
5.93
4.89
4.64
8.91
8.5
26.95
Working capital per share
5.81
6.85
6.35
5.86
9.13
5.62
26.96
Book value per share
6.32
6.1
5.03
4.76
9.01
8.59
27.39
Notizie
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug
Il titolo Soleno Therapeutics tocca il minimo di 52 settimane a 39,42 USD
Soleno Therapeutics stock hits 52-week low at 39.42 USD
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes
Soleno Therapeutics stock price target raised to $120 from $110 at H.C. Wainwright